Teadus Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 2 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.04 M
About Teadus Pharma
Teadus Pharma Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 January 2023 (Two years 24 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.04 M.
Umamaheswar Siripurapu and Selvakumar Balaraman serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230TG2023PTC170281
-
Company No.
170281
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jan 2023
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Teadus Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umamaheswar Siripurapu
|
Director | 10-Jan-2023 | Current |
|
Selvakumar Balaraman
|
Director | 10-Jan-2023 | Current |
Financial Performance of Teadus Pharma.
Enhance accessibility to Teadus Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Teadus Pharma?
Unlock access to Teadus Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Energon Labs Private LimitedUmamaheswar Siripurapu is a mutual person
-
Anvitha Life Care Private LimitedSelvakumar Balaraman is a mutual person
Charges (Loans)
₹2.04 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2023 | Hdfc Bank Limited | ₹2.04 M | Open |
How Many Employees Work at Teadus Pharma?
Unlock and access historical data on people associated with Teadus Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Teadus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Teadus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.